Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

被引：0
|
作者：
F. Wilford Germino
Joel M. Neutel
Robert Dubiel
Jen-Fue Maa
Kathleen J. Chavanu
机构：
[1] Orland Primary Care Specialists,Department of Internal Medicine
[2] Orange County Research Center,undefined
[3] Daiichi Sankyo,undefined
[4] Inc.,undefined
来源：
American Journal of Cardiovascular Drugs | 2012年 / 12卷 / 5期
关键词：
Ambulatory Blood Pressure; Ambulatory Blood Pressure Monitoring; HCTZ; Olmesartan Medoxomil; Blood Pressure Goal;
D O I：
10.1007/BF03261841
中图分类号：
学科分类号：
摘要：
Background: The incidence of hypertension, particularly isolated systolic hypertension, increases with in-creasing age, as does the risk of fatal cardiovascular disease. A combination antihypertensive therapy regimen may be required to reach recommended BP goals in older patients.
引用
收藏
页码：325 / 333
页数：8
相关论文
共 50 条
  • [31] Efficacy and Safety of Two Ramipril and Hydrochlorothiazide Fixed-Dose Combination Formulations in Adults With Stage 1 or Stage 2 Arterial Hypertension Evaluated by Using ABPM
    Oigman, Wille
    Mota Gomes, Marco Antonio
    Pereira-Barretto, Antonio Carlos
    Povoa, Rui
    Kohlmann, Osvaldo
    Rocha, Joao Carlos
    Nobre, Fernando
    CLINICAL THERAPEUTICS, 2013, 35 (05) : 702 - 710
  • [32] Efficacy/Safety of Olmesartan Medoxomil Versus Losartan Potassium in Patients by Stage 1 or 2 Hypertension
    Flack, John M.
    Graff, Alan
    Li, Wei
    Chavanu, Kathleen J.
    POSTGRADUATE MEDICINE, 2012, 124 (03) : 59 - 70
  • [33] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension Focus on Amlodipine/Valsartan
    da Silva, Pedro Marques
    CLINICAL DRUG INVESTIGATION, 2010, 30 (09) : 625 - 641
  • [34] An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension
    Luccioni, R
    Sever, PS
    DiPerri, T
    Redon, J
    Laurandin, I
    Brault, Y
    Chastang, C
    Guez, D
    Andrejak, M
    Araud, JM
    Aupy, JM
    Baclet, JL
    Baixas, JP
    Baud, J
    Billaut, P
    Bin, E
    Bioulac, B
    Blanche, M
    Blondel, D
    Bogetto, D
    Bonneau, D
    Bontemps, P
    Boucher, L
    Bourneuf, P
    Bouvet, P
    Boye, A
    Cabot, JM
    Cahoreau, R
    Calmet, G
    Campard, JC
    Cases, B
    Cassin, H
    Castellani, J
    Clerson, P
    Cognee, F
    CollRotger, J
    Constensoux, JP
    Copere, C
    Cozic, JA
    Dahan, G
    DalleRive, MC
    deSainteLorette, E
    Deltour, LC
    Drugeon, M
    Dubourg, D
    Dupont, S
    Cirica, NE
    ElSawy, A
    Eoche, R
    Etchegaray, G
    JOURNAL OF HYPERTENSION, 1995, 13 (12) : 1847 - 1851
  • [35] The Combination of Olmesartan Medoxomil and Hydrochlorothiazide Is Effective in Patients with Type 2 Diabetes and Hypertension for Achieving BP Goal
    Neutel, Joel M.
    Lewin, Andrew
    Stoakes, Kathy A.
    Waverczak, William F.
    Xu, Jianbo
    Shojaee, Ali
    Dubiel, Robert
    DIABETES, 2009, 58 : A538 - A538
  • [36] Efficacy of olmesartan medoxomil (O) and O/hydrochlorothiazide (H) in achieving blood pressure (BP) control and normalization in stage 2 systolic hypertension (HTN)
    Izzo, J
    Neutel, J
    Dubiel, R
    Walker, F
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 64A - 64A
  • [37] Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use (vol 34, pg 1, 2018)
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2018, 34 (07)
  • [38] Efficacy and safety of a fixed-dose combination of telmisartan 80 mg and hydrochlorothiazide 25 mg in patients with uncontrolled hypertension
    Neldam, S.
    Edwards, C.
    JOURNAL OF HYPERTENSION, 2007, 25 : S114 - S114
  • [39] Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension
    Kereiakes, Dean J.
    Chrysant, Steven G.
    Izzo, Joseph L.
    Littlejohn, Thomas, III
    Oparil, Suzanne
    Melino, Michael
    Lee, James
    Fernandez, Victor
    Heyrman, Reinilde
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (03): : 149 - 157
  • [40] PHASE III STUDY EVALUATING THE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE 40/12.5 MG COMBINATION THERAPY VERSUS OLMESARTAN MEDOXOMIL 40 MG MONOTHERAPY IN PATIENTS WITH ESSENTIAL HYPERTENSION
    Fogari, R.
    Taddei, S.
    Baszak, J.
    Gross-Tyrkin, E.
    Holm-Bentzen, M.
    Karen, I.
    Kvasnicka, J.
    Schell, E.
    Melani, L.
    Schumacher, K.
    JOURNAL OF HYPERTENSION, 2009, 27 : S275 - S275
12345